Log In
BCIQ
Print this Print this
 

CD19

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting CD19

BCIQ
Print ChartPrint this
Marketed, 1 Phase II, 8 Phase II, 1 Phase I/II, 5 Phase I/II, 1 Phase I, 10 Phase I, 2 Preclinical, 6 Preclinical, 1
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase IIMarketed
Autoimmune

1

2

1

1

-

Cancer

6

10

5

8

1




 Products Targeting CD19
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

17

$3,544.1M

$1,489.3M

$1,575.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today